MannKind (MNKD) Q4 Earnings and Revenues Surpass Estimates
MNKDMannKind(MNKD) Zacks Investment Research·2024-02-28 07:36

MannKind (MNKD) came out with quarterly earnings of 0.02pershare,beatingtheZacksConsensusEstimateofalossof0.02 per share, beating the Zacks Consensus Estimate of a loss of 0.01 per share. This compares to loss of 0.07pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof3000.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 300%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of 0.02 per share when it actually produced earnings of $0.02, delivering a surprise of 200%. Over the last four quarters, ...